Arecor operates two complementary tracks: a proprietary clinical pipeline centred on next-generation insulins for pumps and automated insulin delivery systems, and a partnering engine applying Arestat to third-party molecules under formulation-development collaborations. Arestat is the intellectual heart — a proprietary formulation technology overcoming aggregation, …
AstraZeneca is headquartered in Cambridge, organised around four therapy areas: Oncology, Cardiovascular/Renal/Metabolism (CVRM), Respiratory & Immunology, and Rare Disease (built substantially on the 2021 Alexion acquisition). It's a FTSE 100 constituent under ticker AZN, with primary listing in London plus Nasdaq Stockholm; in February …
Following a multi-year restructuring, Avacta describes itself as a pure-play precision oncology company, developing tumour-activated cancer medicines. In March 2025 it sold Launch Diagnostics (a distribution business) for £12.9m, followed in August 2025 by agreeing to sell Coris Bioconcept SRL for roughly £2.2m including …
Genus develops and sells superior animal genetics, principally to pork, dairy and beef producers, allowing farmers to breed livestock that grow more efficiently, produce more milk or meat, and require fewer inputs. Genus PIC (Pig Improvement Company) supplies porcine genetics and is the larger …
Haleon makes and sells branded, largely over-the-counter products for everyday health — oral care, pain relief, vitamins and supplements, respiratory and digestive health, and therapeutic skin health. This is FMCG with a healthcare tilt, not a clinical-stage drug developer. Its 'power brands' include Advil, …
4basebio manufactures synthetic DNA using an enzymatic, cell-free process — marketed as opDNA, and in compact form as hpDNA — for use in mRNA production, gene editing, viral vectors and DNA vaccines. It's also developing Hermes, a non-viral delivery platform pitched as an alternative …
Agronomics Limited is an investment company on AIM under ANIC (also traded in the US as AGNMF), co-founded by investor Jim Mellon, who chairs the board. It takes equity positions in early-stage businesses producing animal products without rearing or slaughtering animals. Crucially, it's a …
Founded in 1998 and headquartered on the English south coast, Allergy Therapeutics develops and sells allergen immunotherapy — treatments seeking to modify the underlying allergic response rather than just suppress symptoms. It markets across continental Europe, principally through German commercial arm Bencard Allergie. The …
Sareum Holdings PLC is a UK-based biotechnology company focused on developing innovative small-molecule therapies for autoimmune diseases and cancer. Rather than generating revenue from commercial products, the company concentrates on advancing promising drug candidates through clinical development with the objective of creating value via …
Verici Dx PLC is a biotechnology company focused on developing advanced diagnostic solutions designed to improve outcomes for organ transplant patients. The company specializes in molecular diagnostics that help clinicians assess transplant rejection risk and optimize patient management through precision medicine.